Table 2. Paired correlations for cancer biomarker expression levels in primary cervical tumors and HPNs (Spearman test).
Expression correlations in tumors | Expression correlation in HPNs | ||||
---|---|---|---|---|---|
Gene pairs | r | p | Gene pairs | r | p |
MUC1 – HER3* | 0.577 | 0.01 | MUC1 – HER3* | 0.679 | 0.003 |
HER1 – HER2* | 0.752 | <0.001 | HER1 – HER2* | 0.608 | 0.01 |
HER2 – HER3* | 0.649 | 0.003 | HER2 – HER3* | 0.679 | 0.003 |
HER3 – uPA* | 0.540 | 0.02 | HER3 – uPA* | 0.613 | 0.009 |
VEGF-C – MMP9* | 0.525 | 0.02 | VEGF-C – MMP9* | 0.667 | 0.003 |
CK19 – HPV16-E6 | 0.498 | 0.03 | CK19 – MUC1 | 0.828 | 0.001 |
HER1 – HER3 | 0.824 | <0.001 | CK19 – HER3 | 0.610 | 0.009 |
HER1 – uPA | 0.473 | 0.04 | HER1 – VEGF | 0.586 | 0.013 |
MMP9 – uPA | 0.639 | 0.003 | HER2 – uPA | 0.672 | 0.003 |
uPA – VEGF-C | 0.505 | 0.039 |
*Shared correlations between primary cervical tumors and HPNs.